Search Results - "Vidili, M G"

Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study by Bertelli, G, Gozza, A, Forno, G B, Vidili, M G, Silvestro, S, Venturini, M, Del Mastro, L, Garrone, O, Rosso, R, Dini, D

“…To evaluate the activity and tolerability of dimethylsulfoxide (DMSO) in the prevention of soft tissue toxicity after extravasation of cytotoxic drugs. From…”
Get more information

Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma by Nobile, M T, Rosso, R, Sertoli, M R, Rubagotti, A, Vidili, M G, Guglielmi, A, Venturini, M, Canobbio, L, Fassio, T, Gallo, L

“…148 patients with advanced untreated colorectal cancer were randomised to receive a weekly bolus of 5-fluorouracil (5-FU) 600 mg/m2 alone, with or without…”
Get more information

Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma by Sertoli, M R, Bernengo, M G, Ardizzoni, A, Brunetti, I, Falcone, A, Vidili, M G, Cusimano, M P, Appino, A, Doveil, G, Fortini, C

“…A pilot study was undertaken to evaluate toxicity and activity of recombinant alpha-2b interferon in patients with metastatic malignant melanoma. Interferon…”
Get more information

Disodium clodronate in the treatment of pain due to bone metastases by Luzzani, M, Vidili, M G, Rissotto, R, Nobile, M T, Beghè, F, Rosso, R, Gottlieb, A

“…Disodium clodronate (dichloromethylene bisphosphonate) a drug belonging to the class of bisphosphonates, inhibits osteoclastic bone resorption and therefore it…”
Get more information

Intrahepatic epidoxorubicin in metastatic and primary liver tumours: a phase II study by Nobile, M T, Vidili, M G, Sertoli, M R, Venturini, M, Simoni, G, Civalleri, D, Bertoglio, S, Percivale, P, Torelli, P, Spagliardi, E

“…Primary and metastatic gastrointestinal tumours in the liver have been treated by intrahepatic artery infusion of chemotherapeutic drugs in an attempt to…”
Get more information

A preliminary clinical study of cyclophosphamide with reduced glutathione as uroprotector by Nobile, M T, Vidili, M G, Benasso, M, Venturini, M, Tedeschi, M, Zunino, F, Rosso, R

“…Reduced glutathione (GSH) has been reported to be an effective protector against cyclophosphamide-induced urotoxicity in experimental models, providing…”
Get more information

Continuous venous infusion of vindesine in metastatic breast cancer: experience with a subcutaneously implanted system and portable pump by Amoroso, D, Bertelli, G, Pronzato, P, Vidili, M G, Gulisano, M, Lionetto, R, Rosso, R

“…Fourteen patients with advanced pretreated breast cancer were treated with vindesine in continuous venous infusion (1.5 mg/sm/24 hours for 72 hours every 3…”
Get more information

Continuous venous infusion of vinblastine in metastatic breast cancer by Pronzato, P, Queirolo, P, Vidili, M G, Amoroso, D, Bertelli, G, Sertoli, M R, Rosso, R

“…In 19 patients with advanced pretreated breast cancer, vinblastine was administered by continuous venous infusion (2 mg/m2/24 h for 120 h every 3 weeks), using…”
Get more information

A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients by Nobile, M T, Canobbio, L, Sobrero, A, Galligioni, E, Vidili, M G, Fassio, T, Lo Re, G, Rubagotti, A, Sertoli, M R, Rosso, R

Get more information

Interim results of intra-arterial 4'-epi-doxorubicin for liver metastases by Simoni, G, Nobile, M T, Repetto, M, Percivale, P L, Razzi, S, Tatarek, R, Vidili, M G, Muggianu, M, Civalleri, D

Get more information

Primary prevention in the young. Methodology and initial results of a smoking prevention program for adolescents by Arciti, C, Vidili, M G, Doglio, B, Gipponi, M, Santi, L

“…An antismoking campaign aimed at the 9-18 year old Genoese school population in 1981-1985 is described. The high percentage of smokers in Italy and the…”
Get more information

Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients by Bernengo, M G, Doveil, G C, Appino, A, Sertoli, M R, Ardizzoni, A, Vidili, M G

Get more information